Education
About Us
Working with TipRanks
Follow Us
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
RESEARCH TOOLSreports
Total Valuation
Dr. Reddy's Laboratories Ltd. has a market cap or net worth of ₹1.04T. The enterprise value is ―.
Market Cap₹1.04T
Enterprise Value―
Share Statistics
Dr. Reddy's Laboratories Ltd. has 834,416,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding834,416,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Dr. Reddy's Laboratories Ltd. is ―. Dr. Reddy's Laboratories Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Dr. Reddy's Laboratories Ltd. had revenue of 279.16B and earned 55.68B in profits. Earnings per share was 334.41.
Revenue279.16B
Gross Profit163.61B
Operating Income67.73B
Pretax Income71.87B
Net Income55.68B
EBITDA88.28B
Earnings Per Share (EPS)334.41
Cash Flow
In the last 12 months, operating cash flow was 35.42B and capital expenditures -29.43B, giving a free cash flow of 5.99B billion.
Operating Cash Flow35.42B
Free Cash Flow5.99B
Free Cash Flow per Share7.18
Dividends & Yields
Dr. Reddy's Laboratories Ltd. pays an annual dividend of ₹8, resulting in a dividend yield of 0.64%
Dividend Per Share₹8
Dividend Yield0.64%
Payout Ratio11.80%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.73
52-Week Price Change7.07%
50-Day Moving Average1.19K
200-Day Moving Average1.26K
Relative Strength Index (RSI)76.32
Average Volume (3m)68.10K
Important Dates
Dr. Reddy's Laboratories Ltd. upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateMay 9, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateJul 10, 2025
Financial Position
Dr. Reddy's Laboratories Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Dr. Reddy's Laboratories Ltd. has paid 16.19B in taxes.
Income Tax16.19B
Effective Tax Rate―
Enterprise Valuation
Dr. Reddy's Laboratories Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Dr. Reddy's Laboratories Ltd. has ₹59.18B in cash and marketable securities with ₹51.09B in debt, giving a net cash position of -₹8.09B billion.
Cash & Marketable Securities₹59.18B
Total Debt₹51.09B
Net Cash-₹8.09B
Net Cash Per Share-₹9.70
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Dr. Reddy's Laboratories Ltd. is ₹1,291.67, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,291.67
Price Target Upside12.45% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―